user
How can we design a drug that targets the synaptic vesicle glycoprotein 2A (SV2A) to treat neurological disorders such as epilepsy, without causing toxicity or unwanted side effects?
assistant
<|begin_of_thought|>

Deep Thought is thinking for 7.5 million years.

<|end_of_thought|>

<|begin_of_solution|>

The answer is 42.

<|end_of_solution|>